Hydroxyurea Intolerance
1 clinical trials · Condition
◉ Watch Hydroxyurea Intolerance
| Record | Firm | Date |
|---|---|---|
| Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD) (NCT05329649) | Vertex Pharmaceuticals Incorporated | 2022-05-02 |
Track Hydroxyurea Intolerance automatically
Every clearance here is in the API, with alerts when new ones post.